MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

68 hedge funds and large institutions have $350M invested in Mirati Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
3
Increased
33
Reduced
18
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AH
1
Aviva Holdings
Bahamas
$33.3M
2
BBA
2
Baker Bros. Advisors
New York
$69.9M
3
QF
3
QVT Financial
New York
$12M
4
PA
4
Perceptive Advisors
New York
$5.84M
5
VAM
5
Visium Asset Management
New York
$13M

Top Sellers

1
BC
1
Boxer Capital
California
$16.2M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$55.9M
3
Morgan Stanley
3
Morgan Stanley
New York
$1.03M
4
DCM
4
Driehaus Capital Management
Illinois
$2.68M
5
SIM
5
Spark Investment Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
QSS
76
Quantitative Systematic Strategies
Florida
– -$393K -12,830 Closed
Balyasny Asset Management
77
Balyasny Asset Management
Illinois
– -$253K -8,020 Closed
AllianceBernstein
78
AllianceBernstein
Tennessee
– -$234K -7,400 Closed
CSS
79
Cubist Systematic Strategies
Connecticut
– -$211K -6,667 Closed
PG
80
PEAK6 Group
Illinois
– -$98K -3,100 Closed
BNP Paribas Financial Markets
81
BNP Paribas Financial Markets
France
– -$71.7K -2,268 Closed
PAM
82
Panagora Asset Management
Massachusetts
– -$44K -1,390 Closed
1 2 3
4